1d
MedPage Today on MSNEnd of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...
11h
The Independent on MSNWhat are the symptoms of prostate cancer and how common is it?What are the symptoms of prostate cancer and how common is it? - Formula One team owner Eddie Jordan has died from the ...
Medical Xpress on MSN10d
Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows"But if you're 50 and have 25 to 30 years in which prostate cancer can become a bigger issue, even with the downsides, most ...
Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.
A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...
Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...
Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...
Through its vast network of top urologists, oncologists, and researchers from world-class institutions, Human Longevity's $1 ...
The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...
Feb. 3, 2025 — The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new ...
Physicians surveyed for a new study said that reports generated by artificial intelligence (AI) were, with a few exceptions, accurate and complete. They could also be modified faster than writing ...
Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market. TAIPEI, Taiwan, March 19, 2025 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results